The 24.8% relative risk reduction in prostate cancer seen in the finasteride arm prompted the early termination of the study on February 21, 2003, 15 months before its anticipated completion. While ...
To earn CME related to this news article, click here. February 25, 2009 — A new joint guideline produced by the American Society of Clinical Oncology (ASCO) and the American Urological Association ...
This article was reviewed by Knox Beasley. 1mg oral finasteride effectively treats hair loss and is the standard dose for male pattern baldness. 5mg oral finasteride is for prostate issues, not hair ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results